Gavin Wood has joined Adaptimmune Therapeutics (NASDAQ: [[ticker:ADAP]]) as chief financial officer, the same role he held most recently at Abcam. His experience also includes senior positions at Affymetrix. Adaptimmune, which splits its operations between Philadelphia and Oxfordshire, UK, is developing cancer immunotherapies based on its proprietary SPEAR T cell platform.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
